For Patients
A brighter future for patients
Our mission is to advance medicines that will provide a brighter future for patients with serious conditions that are not fully served by existing treatments.
Our current focus is brain cancer, including Glioblastoma, Medulloblastoma and Diffuse Midline Glioma.
Glioblastoma (or Glioblastoma multiforme), often abbreviated as GBM, stands as one of the most aggressive and challenging brain tumors known to medical science.
Leptomeningeal disease is a rare but serious complication of cancer that affects the delicate membranes surrounding the brain and spinal cord.
Receiving a diagnosis of diffuse midline glioma can be a challenging and overwhelming experience for both patients and their carers.
Dealing with a diagnosis of medulloblastoma can be overwhelming for both patients and their caregivers.
The battle against brain cancer has been long and arduous. In this blog post, we will explore what CED is...
In the vast landscape of healthcare, rare and orphan diseases often remain unseen and overlooked. Yet, these diseases affect millions...
Childhood Cancer Awareness Month is a powerful time to come together and raise crucial funds for pediatric cancer research, support...
Numerous support groups exist across the United States and the United Kingdom, providing a network of understanding, guidance, and comfort.
Clinical trials play a vital role in advancing medical research and discovering innovative treatments for various health conditions.